PROTECT: The Foundation for the Solid Formulation

PROTECT is the first Phase III program to unequivocally demonstrate that oral delivery of macromolecules is feasible with Emisphere’s eligen™ technology.



• PROTECT established a safety and efficacy profile for the EMISPHERE® delivery agent, SNAC
• Results presented as American Society of Hematology (ASH) annual meeting on 12/9/02

Oral Heparin

Previous slide

Next slide

Back to first slide

View graphic version